Mitchell A. Olman

8.2k total citations · 1 hit paper
68 papers, 3.5k citations indexed

About

Mitchell A. Olman is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Mitchell A. Olman has authored 68 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Mitchell A. Olman's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Protease and Inhibitor Mechanisms (13 papers) and Cell Adhesion Molecules Research (11 papers). Mitchell A. Olman is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Protease and Inhibitor Mechanisms (13 papers) and Cell Adhesion Molecules Research (11 papers). Mitchell A. Olman collaborates with scholars based in United States, China and Japan. Mitchell A. Olman's co-authors include Candece L. Gladson, Kimberly E. White, L. Grove, Brian D. Southern, R.G. Scheraga, K M Moser, Michael A. Matthay, Lorraine B. Ware, Susamma Abraham and Kathryn A. Niese and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Mitchell A. Olman

68 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

2017 280 citations Gísli Jenkins, Bethany B. Moore et al. American Journal of Respiratory Cell and Molecular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitchell A. Olman United States	35	1.7k	870	411	367	357	68	3.5k
Helmut Unruh Canada	32	1.5k 0.9×	885 1.0×	839 2.0×	422 1.1×	154 0.4×	76	3.5k
Yen‐Lin Chen United States	35	1.4k 0.8×	1.0k 1.2×	266 0.6×	113 0.3×	217 0.6×	128	3.3k
Mehrnaz Gharaee‐Kermani United States	34	1.6k 1.0×	975 1.1×	443 1.1×	268 0.7×	266 0.7×	60	3.9k
Toru Hiraga Japan	38	907 0.5×	2.3k 2.6×	397 1.0×	269 0.7×	708 2.0×	101	5.2k
Masamichi Ishizaki Japan	29	756 0.4×	824 0.9×	227 0.6×	187 0.5×	283 0.8×	85	2.9k
Carl Atkinson United States	38	1.6k 1.0×	1.1k 1.2×	325 0.8×	419 1.1×	404 1.1×	141	4.9k
David M. Smadja France	35	720 0.4×	1.4k 1.6×	201 0.5×	268 0.7×	338 0.9×	199	3.5k
Humberto E. Trejo Bittar United States	23	1.2k 0.7×	894 1.0×	332 0.8×	203 0.6×	194 0.5×	60	2.5k
Lee A. Borthwick United Kingdom	30	759 0.4×	738 0.8×	391 1.0×	378 1.0×	213 0.6×	65	3.0k
Eric Camerer United States	32	361 0.2×	1.9k 2.1×	401 1.0×	396 1.1×	537 1.5×	53	5.1k

Countries citing papers authored by Mitchell A. Olman

Since Specialization

Citations

This map shows the geographic impact of Mitchell A. Olman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell A. Olman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell A. Olman more than expected).

Fields of papers citing papers by Mitchell A. Olman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell A. Olman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell A. Olman. The network helps show where Mitchell A. Olman may publish in the future.

Co-authorship network of co-authors of Mitchell A. Olman

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell A. Olman. A scholar is included among the top collaborators of Mitchell A. Olman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell A. Olman. Mitchell A. Olman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roychowdhury, Sanjoy, Mahesha Gangadhariah, Emily S. Cross, et al.. (2024). TRPV4 Regulates the Macrophage Metabolic Response to Limit Sepsis-induced Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 70(6). 457–467. 7 indexed citations

Attaway, Amy, Reena Mehra, Joe Zein, et al.. (2024). Nocturnal Hypoxemia is Associated with Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 21(9). 1316–1325. 3 indexed citations

Southern, Brian D., Haiyan Li, James F. Crish, et al.. (2023). A novel mechanoeffector role of fibroblast S100A4 in myofibroblast transdifferentiation and fibrosis. Journal of Biological Chemistry. 300(1). 105530–105530. 9 indexed citations

Mao, Ren, Geneviève Doyon, Ilyssa O. Gordon, et al.. (2021). Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn’s disease. Gut. 71(1). 55–67. 46 indexed citations

Perelas, Apostolos, et al.. (2021). Stretching the Function of Innate Immune Cells. Frontiers in Immunology. 12. 767319–767319. 56 indexed citations

Scheraga, R.G., Susamma Abraham, L. Grove, et al.. (2020). TRPV4 Protects the Lung from Bacterial Pneumonia via MAPK Molecular Pathway Switching. The Journal of Immunology. 204(5). 1310–1321. 49 indexed citations

Todd, Jamie L., Richard Vinisko, Yi Liu, et al.. (2020). Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort. BMC Pulmonary Medicine. 20(1). 64–64. 68 indexed citations

Grove, L., Maradumane L. Mohan, Susamma Abraham, et al.. (2019). Translocation of TRPV4-PI3Kγ complexes to the plasma membrane drives myofibroblast transdifferentiation. Science Signaling. 12(607). 37 indexed citations

Jenkins, Gísli, Bethany B. Moore, Rachel C. Chambers, et al.. (2017). An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 56(5). 667–679. 280 indexed citations breakdown →

10.

Neto, Manuel L. Ribeiro, Marie Budev, Daniel A. Culver, et al.. (2017). Venous Thromboembolism After Adult Lung Transplantation. Transplantation. 102(4). 681–687. 32 indexed citations

11.

Rahaman, Shaik O., L. Grove, Brian D. Southern, et al.. (2015). Role of Cation Channel TRPV4 in Mechanosensing, Myofibroblast Differentiation, and Pulmonary Fibrosis. Annals of the American Thoracic Society. 12(Supplement_1). S74–S75. 1 indexed citations

12.

Ding, Qiang, Meng Hu, Youfeng Yang, et al.. (2013). FAK-Related Nonkinase Is a Multifunctional Negative Regulator of Pulmonary Fibrosis. American Journal Of Pathology. 182(5). 1572–1584. 46 indexed citations

13.

Noth, Imre & Mitchell A. Olman. (2012). Reply: Is Warfarin the Right Anticoagulant in Idiopathic Pulmonary Fibrosis?. American Journal of Respiratory and Critical Care Medicine. 186(7). 693–694. 1 indexed citations

14.

Noth, Imre, Kevin J. Anstrom, Sara B. Calvert, et al.. (2012). A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 186(1). 88–95. 317 indexed citations

15.

Wang, Dongyan, Mitchell A. Olman, Ping Huang, et al.. (2011). Downregulation of FIP200 Induces Apoptosis of Glioblastoma Cells and Microvascular Endothelial Cells by Enhancing Pyk2 Activity. PLoS ONE. 6(5). e19629–e19629. 24 indexed citations

16.

Ding, Qiang, Candece L. Gladson, Hongju Wu, Haruko Hayasaka, & Mitchell A. Olman. (2008). Focal Adhesion Kinase (FAK)-related Non-kinase Inhibits Myofibroblast Differentiation through Differential MAPK Activation in a FAK-dependent Manner. Journal of Biological Chemistry. 283(40). 26839–26849. 78 indexed citations

17.

Olman, Mitchell A., Kimberly E. White, Lorraine B. Ware, et al.. (2004). Pulmonary Edema Fluid from Patients with Early Lung Injury Stimulates Fibroblast Proliferation through IL-1β-Induced IL-6 Expression. The Journal of Immunology. 172(4). 2668–2677. 106 indexed citations

18.

Prabhakaran, Priya, et al.. (2003). Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 285(1). L20–L28. 206 indexed citations

19.

Lang, Iréne, et al.. (1994). Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli.. Circulation. 89(6). 2715–2721. 81 indexed citations

20.

Olman, Mitchell A., et al.. (1990). Pulmonary Vascular Steal in Chronic Thromboembolic Pulmonary Hypertension. CHEST Journal. 98(6). 1430–1434. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact